Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Falconi

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|September 20, 2013
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromesEmiliano Fabiani, Luana Fianchi, Giulia Falconi, et al.
Frontiers in Oncology|May 2, 2022
Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and PrognosisLuca Guarnera, Tiziana Ottone, Emiliano Fabiani, et al.
Experimental Hematology|November 2, 2015
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromesGiulia Falconi, Emiliano Fabiani, Luana Fianchi, et al.
Scientific Reports|December 9, 2022
Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesisGiulia Falconi, Elisa Galossi, Emiliano Fabiani, et al.
Molecular and Clinical Oncology|February 23, 2018
Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemiaCarmelo Gurnari, Paola Panetta, Emiliano Fabiani, et al.
Oncotarget|January 12, 2017
Clonal evolution in therapy-related neoplasmsEmiliano Fabiani, Giulia Falconi, Luana Fianchi, et al.
Leukemia Research|August 7, 2019
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndromeGiulia Falconi, Emiliano Fabiani, Marianna Criscuolo, et al.
Oncotarget|November 16, 2017
The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemiaEmiliano Fabiani, Giulia Falconi, Nélida Inés Noguera, et al.
Leukemia Research|October 22, 2020
Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid LeukemiaEleonora De Bellis, Tiziana Ottone, Lisa Mercante, et al.
Cancers|September 19, 2019
Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic SyndromesIsabella Faraoni, Maria Irno Consalvo, Francesca Aloisio, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|September 20, 2013
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromesEmiliano Fabiani, Luana Fianchi, Giulia Falconi, et al.
Frontiers in Oncology|May 2, 2022
Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and PrognosisLuca Guarnera, Tiziana Ottone, Emiliano Fabiani, et al.
Experimental Hematology|November 2, 2015
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromesGiulia Falconi, Emiliano Fabiani, Luana Fianchi, et al.
Scientific Reports|December 9, 2022
Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesisGiulia Falconi, Elisa Galossi, Emiliano Fabiani, et al.
Molecular and Clinical Oncology|February 23, 2018
Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemiaCarmelo Gurnari, Paola Panetta, Emiliano Fabiani, et al.
Oncotarget|January 12, 2017
Clonal evolution in therapy-related neoplasmsEmiliano Fabiani, Giulia Falconi, Luana Fianchi, et al.
Leukemia Research|August 7, 2019
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndromeGiulia Falconi, Emiliano Fabiani, Marianna Criscuolo, et al.
Oncotarget|November 16, 2017
The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemiaEmiliano Fabiani, Giulia Falconi, Nélida Inés Noguera, et al.
Leukemia Research|October 22, 2020
Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid LeukemiaEleonora De Bellis, Tiziana Ottone, Lisa Mercante, et al.
Cancers|September 19, 2019
Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic SyndromesIsabella Faraoni, Maria Irno Consalvo, Francesca Aloisio, et al.
Pageof 3